Parachlamydia acanthamoebae has been implicated as an emerging agent of pneumonia in humans. Recently, it has been linked to miscarriage and neonatal infections. In contrast, its role in atherosclerosis remains controversial. In animals, there is strong evidence for Parachlamydia as a new abortigenic in cattle, and further data on this agent in other animal species is accumulating. New diagnostic methods, such as specific real-time PCR and immunohistochemistry with specific anti-Parachlamydia antibodies to detect the organism within lesions, are now available to facilitate the diagnosis of parachlamydial infections in humans and animals. This review discusses parachlamydial infections in clinical settings in humans and animals, as well as their zoonotic potential and possible modes of transmission. Current diagnostic tools are presented, and finally, the antibiotic susceptibility of Parachlamydia is described for potential future preventive and therapeutic options. Nevertheless, more data on Parachlamydia and Chlamydia-like organisms are needed to elucidate their host range and pathogenic potential in humans and animals. 
Cervical swabs and genital tracts of sows were examined in a recent study on the 132 diagnostic investigation into the role of chlamydiae in cases of increased rates of return 133 to estrus in pigs (22). By broad-range 16S rRNA PCR amplifying short-length 134 fragments, DNA of Chlamydia-like organisms were detected in 28.2% on the swabs 135 from sows with and 22.0% of sows without reproductive problems, respectively 136 (p>0.05). Although there was no significant difference between the two groups, the high 137 aborted fetuses was unexpected. 139
By the same method, DNA of Chlamydia-like organisms was detected in semen of 140 boars (23). However, the significance of this finding related to reproductive disorders in 141 boars and sows remains to be elucidated. 142
143

Other mammals 144
An association of ocular diseases in cats, koalas, guinea pigs, pigs and sheep with 145
Chlamydia-like organisms was reported as DNA of these bacteria was amplified by PCR 146 (24-29). However, the pathogenicity of these organisms remains unclear and need 147 further investigation. 148
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P. acanthamoebae is considered as an emerging agent of pneumonia in humans 
